38443977|t|TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.
38443977|a|BACKGROUND: There is a lack of effective therapeutic strategies for amyotrophic lateral sclerosis (ALS); therefore, drug repurposing might provide a rapid approach to meet the urgent need for treatment. METHODS: To identify therapeutic targets associated with ALS, we conducted Mendelian randomization (MR) analysis and colocalization analysis using cis-eQTL of druggable gene and ALS GWAS data collections to determine annotated druggable gene targets that exhibited significant associations with ALS. By subsequent repurposing drug discovery coupled with inclusion criteria selection, we identified several drug candidates corresponding to their druggable gene targets that have been genetically validated. The pharmacological assays were then conducted to further assess the efficacy of genetics-supported repurposed drugs for potential ALS therapy in various cellular models. RESULTS: Through MR analysis, we identified potential ALS druggable genes in the blood, including TBK1 [OR 1.30, 95%CI (1.19, 1.42)], TNFSF12 [OR 1.36, 95%CI (1.19, 1.56)], GPX3 [OR 1.28, 95%CI (1.15, 1.43)], TNFSF13 [OR 0.45, 95%CI (0.32, 0.64)], and CD68 [OR 0.38, 95%CI (0.24, 0.58)]. Additionally, we identified potential ALS druggable genes in the brain, including RESP18 [OR 1.11, 95%CI (1.07, 1.16)], GPX3 [OR 0.57, 95%CI (0.48, 0.68)], GDF9 [OR 0.77, 95%CI (0.67, 0.88)], and PTPRN [OR 0.17, 95%CI (0.08, 0.34)]. Among them, TBK1, TNFSF12, RESP18, and GPX3 were confirmed in further colocalization analysis. We identified five drugs with repurposing opportunities targeting TBK1, TNFSF12, and GPX3, namely fostamatinib (R788), amlexanox (AMX), BIIB-023, RG-7212, and glutathione as potential repurposing drugs. R788 and AMX were prioritized due to their genetic supports, safety profiles, and cost-effectiveness evaluation. Further pharmacological analysis revealed that R788 and AMX mitigated neuroinflammation in ALS cell models characterized by overly active cGAS/STING signaling that was induced by MSA-2 or ALS-related toxic proteins (TDP-43 and SOD1), through the inhibition of TBK1 phosphorylation. CONCLUSIONS: Our MR analyses provided genetic evidence supporting TBK1, TNFSF12, RESP18, and GPX3 as druggable genes for ALS treatment. Among the drug candidates targeting the above genes with repurposing opportunities, FDA-approved drug-R788 and AMX served as effective TBK1 inhibitors. The subsequent pharmacological studies validated the potential of R788 and AMX for treating specific ALS subtypes through the inhibition of TBK1 phosphorylation.
38443977	0	4	TBK1	Gene	29110
38443977	48	77	amyotrophic lateral sclerosis	Disease	MESH:D000690
38443977	245	274	amyotrophic lateral sclerosis	Disease	MESH:D000690
38443977	276	279	ALS	Disease	MESH:D000690
38443977	437	440	ALS	Disease	MESH:D000690
38443977	558	561	ALS	Disease	MESH:D000690
38443977	675	678	ALS	Disease	MESH:D000690
38443977	1017	1020	ALS	Disease	MESH:D000690
38443977	1111	1114	ALS	Disease	MESH:D000690
38443977	1155	1159	TBK1	Gene	29110
38443977	1191	1198	TNFSF12	Gene	8742
38443977	1230	1234	GPX3	Gene	2878
38443977	1266	1273	TNFSF13	Gene	8741
38443977	1309	1313	CD68	Gene	968
38443977	1383	1386	ALS	Disease	MESH:D000690
38443977	1427	1433	RESP18	Gene	389075
38443977	1465	1469	GPX3	Gene	2878
38443977	1501	1505	GDF9	Gene	2661
38443977	1541	1546	PTPRN	Gene	5798
38443977	1590	1594	TBK1	Gene	29110
38443977	1596	1603	TNFSF12	Gene	8742
38443977	1605	1611	RESP18	Gene	389075
38443977	1617	1621	GPX3	Gene	2878
38443977	1739	1743	TBK1	Gene	29110
38443977	1745	1752	TNFSF12	Gene	8742
38443977	1758	1762	GPX3	Gene	2878
38443977	1771	1783	fostamatinib	Chemical	MESH:C523665
38443977	1785	1789	R788	Chemical	-
38443977	1792	1801	amlexanox	Chemical	MESH:C045742
38443977	1803	1806	AMX	Chemical	MESH:C045742
38443977	1809	1817	BIIB-023	Chemical	MESH:C586995
38443977	1819	1826	RG-7212	Chemical	MESH:C000601202
38443977	1832	1843	glutathione	Chemical	MESH:D005978
38443977	1876	1880	R788	Chemical	-
38443977	1885	1888	AMX	Chemical	MESH:C045742
38443977	2036	2040	R788	Chemical	-
38443977	2045	2048	AMX	Chemical	MESH:C045742
38443977	2059	2076	neuroinflammation	Disease	MESH:D000090862
38443977	2080	2083	ALS	Disease	MESH:D000690
38443977	2127	2131	cGAS	Gene	115004
38443977	2132	2137	STING	Gene	340061
38443977	2168	2173	MSA-2	CellLine	CVCL:AD05
38443977	2177	2180	ALS	Disease	MESH:D000690
38443977	2205	2211	TDP-43	Gene	23435
38443977	2216	2220	SOD1	Gene	6647
38443977	2249	2253	TBK1	Gene	29110
38443977	2337	2341	TBK1	Gene	29110
38443977	2343	2350	TNFSF12	Gene	8742
38443977	2352	2358	RESP18	Gene	389075
38443977	2364	2368	GPX3	Gene	2878
38443977	2392	2395	ALS	Disease	MESH:D000690
38443977	2509	2513	R788	Chemical	-
38443977	2518	2521	AMX	Chemical	MESH:C045742
38443977	2542	2546	TBK1	Gene	29110
38443977	2625	2629	R788	Chemical	-
38443977	2634	2637	AMX	Chemical	MESH:C045742
38443977	2660	2663	ALS	Disease	MESH:D000690
38443977	2699	2703	TBK1	Gene	29110
38443977	Association	MESH:D000690	8741
38443977	Association	MESH:D005978	6647
38443977	Association	MESH:D005978	MESH:D000690
38443977	Association	MESH:D000690	23435
38443977	Association	MESH:D000090862	23435
38443977	Association	MESH:C000601202	115004
38443977	Association	MESH:C586995	23435
38443977	Association	MESH:D005978	340061
38443977	Association	MESH:D000690	2661
38443977	Association	MESH:D000090862	340061
38443977	Association	MESH:C000601202	MESH:D000090862
38443977	Association	MESH:D000690	29110
38443977	Association	MESH:C000601202	MESH:C586995
38443977	Association	MESH:C000601202	6647
38443977	Association	MESH:C586995	MESH:D005978
38443977	Negative_Correlation	MESH:C045742	MESH:D000090862
38443977	Association	MESH:C000601202	23435
38443977	Association	115004	6647
38443977	Association	MESH:C045742	23435
38443977	Association	MESH:D000690	8742
38443977	Association	MESH:D000690	2878
38443977	Association	MESH:C000601202	MESH:C045742
38443977	Association	MESH:C586995	MESH:D000090862
38443977	Association	MESH:D000090862	6647
38443977	Association	MESH:C586995	115004
38443977	Association	MESH:D005978	23435
38443977	Association	MESH:C586995	340061
38443977	Association	115004	23435
38443977	Association	MESH:C000601202	MESH:D005978
38443977	Association	MESH:C045742	MESH:C586995
38443977	Association	MESH:C000601202	340061
38443977	Association	MESH:D000690	389075
38443977	Association	23435	6647
38443977	Negative_Correlation	MESH:C045742	340061
38443977	Association	MESH:D000690	6647
38443977	Negative_Correlation	MESH:C045742	MESH:D005978
38443977	Association	MESH:D000690	968
38443977	Association	340061	6647
38443977	Association	23435	340061
38443977	Association	MESH:D000090862	115004
38443977	Association	MESH:C586995	6647
38443977	Association	MESH:D000690	5798
38443977	Association	MESH:D005978	MESH:D000090862
38443977	Association	MESH:D005978	115004

